Join to View Full Profile
775 Poplar RdSte 310Newnan, GA 30265
Phone+1 770-251-2590
Fax+1 770-251-1490
Dr. Assikis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Vasileios Assikis is an oncologist in Newnan, GA and is affiliated with multiple hospitals in the area, including Piedmont Hospital and Piedmont Newnan Hospital. He received his medical degree from Aristotle University of Thessaloniki School of Medicine and has been in practice 26 years. He specializes in breast cancer, genitourinary oncology, and hematologic oncology and is experienced in hematologic oncology, breast cancer, prostate cancer, gynecologic oncology, and urologic oncology.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 2000 - 2003
Cook County Health and Hospitals SystemResidency, Internal Medicine, 1996 - 2000
Aristotle University of Thessaloniki School of MedicineClass of 1991
Certifications & Licensure
GA State Medical License 2003 - 2025
TX State Medical License 2000 - 2004
IL State Medical License 1996 - 2002
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Atlanta Magazine: Top Doctors Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification ARIA Radiation Oncology EMR, Varian Medical Systems, 2012
Clinical Trials
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer Start of enrollment: 2019 Jan 01
Publications & Presentations
PubMed
- 68 citationsTRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer.Samuel R. Denmeade, Hao Wang, Neeraj Agarwal, David Smith, Michael T. Schweizer
Journal of Clinical Oncology. 2021-02-22 - 159 citationsPhase II Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Minimally Symptomatic Metastatic Castrate-Resistant Prostate CancerRoberto Pili, Michael Häggman, Walter M. Stadler, Jeffrey R. Gingrich, Vasileios J. Assikis
Journal of Clinical Oncology. 2011-10-20 - 2 citationsChemoprevention in prostate cancer.Vasileios Assikis, Otis W. Brawley
Current Problems in Cancer. 2004-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
